Biovaxys Technology Corp
(MENAFN- Baystreet) 09:38 AM EST - BioVaxys Technology Corp : Along with SpayVac for Wildlife, Inc. are pleased to jointly announce an expansion of the Fields of Use in the current License Agreement to include commercial aquaculture, plus the farm-raised fish market. With this expansion in the Fields of Use, SpayVac-for-Wildlife's markets now include its no-booster fertility-control vaccines for aquaculture as well as overabundant feral/wild/invasive animals, and select production and companion animals, which significantly increases SpayVac's global revenue potential. BioVaxys Technology Corp
shares C are trading off $0.02 at $0.03.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- Brazil Edtech Market Size, Share, Trends, And Forecast 2025-2033
- Vietnam Vegan Food Market Size, Share, Trends And Report 2025-2033
- Cryptogames Introduces Platform Enhancements Including Affiliate Program Changes
- Accounting And Bookkeeping Service Business Plan 2025: How To Start, Operate, And Grow
- USDT0 And Xaut0 Are Now Live On Polygon
- Global Open Banking Market 20252033: Services, Deployment & Distribution Trends
More Story
Comments
No comment